Trial intelligence / Profile preview

Omeprazole versus ranitidine for gastroesophageal reflux disease in preterm neonates

IRCT2016030226876N1Phase 4Completed

Sponsor
Investigator
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of omeprazole and ranitidine in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Investigator. Started Sep 2013; status: completed.

02

Drugs

omeprazoleranitidine
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on IRCT2016030226876N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016030226876N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call